Feb 24, 2021 8:29am EST Benitec Biopharma Announces Successful Results from the Interim Analysis of the BB-301 Pilot Dosing Study
Oct 06, 2020 4:05pm EDT Benitec Biopharma Announces Closing of $11.5 Million Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares
Sep 23, 2020 4:54pm EDT Benitec Biopharma Provides Operational Update and Releases its 2020 Fiscal Year-End Financial Results
Sep 01, 2020 8:15am EDT Benitec Biopharma to present at H.C. Wainwright's 22nd Annual Global Investment Conference
Apr 15, 2020 8:52am EDT Benitec Biopharma Announces the Completion of Redomiciliation to the United States
